22 studies found for:    "Shigellosis"
Show Display Options
RSS Create an RSS feed from your search for:
"Shigellosis"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Withdrawn Shigella Sonnei OSPC-rDT Conjugate Vaccine
Condition: Shigellosis
Intervention: Drug: CP
2 Completed Safety Study of Inactivated Shigella Whole Cell Vaccine in Adults
Condition: Shigellosis
Intervention: Biological: Shigella flexneri 2a whole cell killed vaccine (Sf2aWC)
3 Completed Shigella Sonnel O-SPC/rBRU Conjugate Vaccine
Conditions: Immunogenicity;   Shigellosis
Intervention: Biological: Shigella Sonnei O-SPC/rBRU
4 Recruiting A Phase 1, Dose Escalation Study, to Evaluate a New Shigella Sonnei Vaccine in Healthy Adults.
Condition: Shigellosis
Interventions: Biological: 1790GAHB vaccine;   Biological: GAHB-Placebo
5 Recruiting Evaluate a New Shigella Sonnei Vaccine Administered Either by Intradermal, Intranasal or Intramuscular Route in Healthy Adults
Condition: Shigellosis
Interventions: Biological: 1790GAHB vaccine;   Biological: GAHB-Placebo
6 Completed Therapeutic Induction of Endogenous Antibiotics
Condition: Shigellosis
Interventions: Biological: Sodium Butyrate;   Biological: Saline
7 Completed
Has Results
Safety, Immunogenicity and Efficacy of Shigella Conjugate Vaccines in 1-4 Year Olds in Israel
Condition: Shigellosis
Intervention: Biological: Shigella conjugate vaccines
8 Recruiting Safety and Immunogenicity of Two Live, Attenuated Oral Shigella Sonnei Vaccines: WRSs2 and WRSs3
Condition: Shigella Infection
Interventions: Other: Placebo;   Biological: WRSs2;   Biological: WRSs3
9 Completed Safety and Efficacy Study of CVD 1208S, a Live, Attenuated Oral Vaccine to Prevent Shigella Infection Using cGMP
Condition: Shigella
Interventions: Biological: CVD 1208S, a Shigella flexneri 2a live, oral vaccine;   Other: Placebo
10 Terminated Safety and Efficacy Challenge Study of CVD 1208S, a Live, Attenuated Oral Vaccine to Prevent Shigella: Phase IIb
Condition: Shigella
Intervention: Biological: CVD 1208S, Challenge strain of wild-type Shigella flexneri 2a
11 Terminated Safety and Efficacy Study of CVD 1208S, a Live, Attenuated Oral Vaccine to Prevent Shigella Infection: Phase IIa
Condition: Shigella
Interventions: Biological: CVD 1208S, a Shigella flexneri 2a live, oral vaccine;   Other: Placebo
12 Completed Healthy Adult Volunteer Study for Two Doses of a Shigella Vaccine
Condition: Shigella Infection
Intervention: Biological: SC599
13 Completed Safety and Reactogenicity of Bioconjugate Vaccine to Prevent Shigella
Condition: Shigellosis
Intervention: Biological: Shigella vaccine
14 Completed Shigella Flexneri 2a Invaplex 50 Vaccine Dose Finding and Assessment of Protection
Condition: Shigellosis
Intervention: Biological: Invaplex 50 Vaccine
15 Completed Safety and Efficacy Study of WRSS1, a Shigella Sonnei Vaccine Candidate
Conditions: Dysentery;   Shigella;   Diarrhea
Interventions: Biological: WRSS1 vaccine;   Biological: Placebo vaccine
16 Not yet recruiting Diagnosis of Neglected Tropical Diseases Among Patients With Persistent Digestive Disorders
Conditions: Soil-transmitted Helminthiasis;   Schistosomiasis;   Strongyloidiasis;   Shigellosis;   Intestinal Salmonellosis;   Campylobacteriosis;   Aeromonas Spp. Infections;   Giardiasis;   Amoebiasis;   Dientamoebiasis;   Cryptosporidium Spp. Infections
Interventions: Procedure: Stool culturing for pathogenic bacteria;   Procedure: Kato-Katz technique;   Procedure: Baermann technique;   Device: Mini-FLOTAC;   Device: Crypto/Giardia Duo Strip;   Procedure: Formalin-ether concentration technique;   Device: CCA RDT;   Procedure: Koga agar plate culture;   Procedure: Kinyoun staining;   Device: Multiplex PCR;   Procedure: Metagenomics analysis
17 Completed Zinc Supplementation in Shigella Patients
Condition: Testing Effect of Intervention
Intervention: Drug: Children in the zinc group received 20 mg of elemental zinc as acetate per day in a twice-daily dose for two weeks.
18 Not yet recruiting Safety Study of Live Shigella Vaccine in Bangladeshi Adults and Children
Condition: Diarrhea
Intervention: Biological: WRSS1
19 Active, not recruiting A Registry Study on Xiyanping(a Chinese Medicine Injection) Used in Fifty Hospitals
Conditions: Viral Pneumonia;   Bronchitis;   Infantile Diarrhea;   Bacillary Dysentery;   Virus Hepatitis
Intervention:
20 Completed Invaplex 50 Vaccine Dose-Ranging
Condition: Diarrhea
Intervention: Biological: Shigella flexneri 2a Invaplex 50

Previous Page Studies Shown (1-20) Next Page (21-22) Show next page of results
Indicates status has not been verified in more than two years